09.28.2015
Prevent & Delay
$3,000,000.00
42 months
Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes (INNODIA)
Funds will support KU Leuven, the coordinating center of the IMI2-supported INNODIA consortium, which focus on developing novel biomarkers and therapeutics to prevent and/or delay the progression of type 1 diabetes.